Login to Your Account

Analyst: Could Boost Sanofi's Bid

Genzyme Genetics Goes for $925M in Deal with LabCorp

By Jennifer Boggs

Tuesday, September 14, 2010
Genzyme Corp. landed a better-than-expected deal for its genetic testing business, selling Genzyme Genetics to Laboratory Corp. of America for $925 million in cash and increasing the odds that Sanofi-Aventis SA could raise its acquisition bid. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription